Showing results (921-930 of 996) with videos related to

Sort By:
Pageof 100
JCO Precision Oncology|September 11, 2020
High Expression of FGD3, a Putative Regulator of Cell Morphology and Motility, Is Prognostic of Favorable Outcome in Multiple CancersScooter Willis, Yuliang Sun, Mark Abramovitz, et al.
Lung Cancer (Amsterdam, Netherlands)|January 9, 2021
Immunotherapy in advanced Non-Small Cell Lung Cancer patients with poor performance status: The role of clinical-pathological variables and inflammatory biomarkersRiccardo Lobefaro, Giuseppe Viscardi, Raimondo Di Liello, et al.
The Oncologist|March 10, 2026
Long-Term Health-Related Quality of Life and Lifestyle Behavior of Patients with Acute Myeloid LeukemiaFabio Efficace, Laura Cannella, Xavier Thomas, et al.
Journal of Medical Virology|August 11, 2025
Oropouche Virus Importation in Southern Brazil and Emerging Concern Calling for Enhanced Public Health SurveillanceFranciellen Machado Dos Santos, Elverson Soares de Melo, Gustavo Barbosa de Lima, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
The Target ALS Global Natural History Study: Cross-platform proteomics to accelerate biofluid biomarker and drug target discovery in amyotrophic lateral sclerosisDaisuke Yasui, Daniel Weatherill, Laura Dugom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2015
Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199Bryan P Schneider, Lang Li, Milan Radovich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2013
Prognostic and predictive value of tumor vascular endothelial growth factor gene amplification in metastatic breast cancer treated with paclitaxel with and without bevacizumab; results from ECOG 2100 trialBryan P Schneider, Robert J Gray, Milan Radovich, et al.
NPJ Breast Cancer|September 2, 2022
Assessment of MRI to estimate metastatic dissemination risk and prometastatic effects of chemotherapyGeorge S Karagiannis, Anthony Bianchi, Luis Rivera Sanchez, et al.
Nature Immunology|February 15, 2024
IL-23 stabilizes an effector Treg cell program in the tumor microenvironmentTobias Wertheimer, Pascale Zwicky, Lukas Rindlisbacher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2025
A Phase II Trial to Evaluate the Safety and Immunogenicity of Two Doses of a Folate Receptor Alpha Vaccine in Patients with Triple-Negative Breast CancerKeith L Knutson, Hala Abu-Fares, Patricia Keating, et al.
Pageof 100